SpinaFX Medical
Lewis Rose, FCPA, FCA, ICD.D has a diverse and extensive work experience. Lewis is currently a Board Director at Far East Food Products Limited since February 2023. Prior to that, they served as a Strategic Advisor at Sonora Foods Ltd. Lewis'sother board director positions include SpinaFX Medical, ABI LTD, and Sabra Enterprises Corp. In addition, Lewis has also worked as a Mentor/Advisor at the Creative Destruction Lab, Rotman, University of Toronto. Lewis has been actively involved in academic roles, serving on the Academic Board and Governing Council at the University of Toronto.
Before their board positions, Lewis held significant leadership roles. Lewis was the CEO and Corporate Director at Sabra Enterprises Corp. Lewis also served as the Chairman and Chief Executive Officer at BakerStone International, leading the company's operations in Los Angeles and Toronto. Lewis has been a Partner in Turnaround Management at Farber Financial Group, where they provided strategic counsel and implementation expertise to various organizations. Prior to that, they worked as Principal at Blueprint Partners International, offering guidance to troubled companies in achieving transformation and growth.
Overall, Lewis Rose's work experience encompasses roles in board leadership, advisory positions, academic involvement, and executive positions focusing on corporate strategy, transformation, and growth.
Lewis Rose, FCPA, FCA, ICD.D has an extensive education history. Lewis began their academic journey at Sea Point Boys' High School, although specific dates are unavailable for this period.
In 1977, Rose enrolled at the University of Toronto - New College, where they pursued a Bachelor of Commerce (B.Com) degree in Accounting, Finance, and Economics. Lewis completed this program in 1981.
Later that same year, Rose joined the Institute of Chartered Accountants of Ontario, where they studied to become a Chartered Accountant. This program, which focused on accountancy skills and knowledge, spanned from 1981 to 1983.
In 2010 and 2011, Rose attended the Institute of Corporate Directors and the University of Toronto - Rotman School of Management, respectively. These experiences led to their attainment of the ICD.D degree from both institutions. Specifically, at the University of Toronto, they studied through the Institute of Corporate Directors program.
In 2012, Rose pursued further education at the Chartered Professional Accountants of Canada (CPA Canada), where they earned the CPA, CA degree.
Most recently, in 2020, Rose once again engaged with the Chartered Professional Accountants of Canada (CPA Canada), this time achieving the prestigious FCPA, FCA designation.
Overall, Lewis Rose, FCPA, FCA, ICD.D possesses a diverse range of academic achievements from various esteemed institutions, which have equipped him with a strong educational foundation in accounting, finance, and corporate governance.
This person is not in any teams
SpinaFX Medical
SpinaFX is a medical device company bringing innovative, minimally invasive image-guided treatments to patients with back pain due to herniated discs. Our patented technology provides surgeons an earlier alternative to conventional surgery, using a minimally invasive technique to deliver a controlled Oxygen formulation to the affected disc, safelyreducing the herniation and inflammation causing pain. SpinaFX's Triojection™ product was previously CE Marked under MDD and is undergoing re-certification under MDR. Triojection is not yet approved for sale in the North America, the UK or the EU.